LE-Lrrk2em1Sage-/- |
serum lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
11.5 |
ng/ml |
3.44 |
7.7 |
automated serum protein analysis |
0.0 |
0 |
104394 |
2947 |
Crl:LE |
serum osteopontin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
11.5 |
ng/ml |
0.49 |
1.1 |
automated serum protein analysis |
0.0 |
0 |
104395 |
2947 |
LE-Lrrk2em1Sage-/- |
serum beta-2 microglobulin |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
67.5 |
ug/ml |
9.26 |
20.7 |
automated serum protein analysis |
0.0 |
0 |
104400 |
2947 |
Crl:LE |
serum clusterin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
144.0 |
ng/ml |
7.38 |
16.5 |
automated serum protein analysis |
0.0 |
0 |
104403 |
2947 |
LE-Lrrk2em1Sage-/- |
serum cystatin C level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood cystatin C amount |
male |
91 days
| 5 |
920.0 |
ng/ml |
72.45 |
162.0 |
automated serum protein analysis |
0.0 |
0 |
104406 |
2947 |
LE-Lrrk2em1Sage-/- |
serum vascular endothelial growth factor A level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
224.0 |
pg/ml |
49.64 |
111.0 |
automated serum protein analysis |
0.0 |
0 |
104414 |
2947 |
Crl:LE |
serum lipocalin 2 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
38.6 |
ng/ml |
1.92 |
4.3 |
automated serum protein analysis |
0.0 |
0 |
104393 |
2947 |
Crl:LE |
serum KIM-1/TIM-1/HAVCR1 |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
0.1 |
ng/ml |
0.0 |
0.01 |
automated serum protein analysis |
0.0 |
0 |
104397 |
2947 |
LE-Lrrk2em1Sage-/- |
serum KIM-1/TIM-1/HAVCR1 |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
0.04 |
ng/ml |
0.0 |
0.01 |
automated serum protein analysis |
0.0 |
0 |
104398 |
2947 |
Crl:LE |
serum cystatin C level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood cystatin C amount |
male |
91 days
| 5 |
1104.0 |
ng/ml |
84.52 |
189.0 |
automated serum protein analysis |
0.0 |
0 |
104405 |
2947 |
SHR/NHsdMco |
serum total protein level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood total protein amount |
male |
140 days
| 6 |
6.4 |
g/dl |
0.12 |
0.29 |
automated serum protein analysis |
0.0 |
0 |
67982 |
834 |
Crl:LE |
serum calbindin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
0.2 |
ng/ml |
0.04 |
0.1 |
automated serum protein analysis |
0.0 |
0 |
104401 |
2947 |
LE-Lrrk2em1Sage-/- |
serum glutathione S-transferase-alpha level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
1126.0 |
ng/ml |
151.61 |
339.0 |
automated serum protein analysis |
0.0 |
0 |
104408 |
2947 |
Crl:LE |
serum glutathione S-transferase-u level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
4.2 |
ug/ml |
1.3 |
2.9 |
automated serum protein analysis |
0.0 |
0 |
104409 |
2947 |
Crl:LE |
serum tissue inhibitor of metalloproteinase 1 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
8.3 |
ng/ml |
0.27 |
0.6 |
automated serum protein analysis |
0.0 |
0 |
104411 |
2947 |
SS/JrTol |
serum total protein level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood total protein amount |
male |
140 days
| 6 |
6.7 |
g/dl |
0.13 |
0.32 |
automated serum protein analysis |
0.0 |
0 |
67981 |
834 |
LE-Lrrk2em1Sage-/- |
serum osteopontin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
13.0 |
ng/ml |
2.41 |
5.4 |
automated serum protein analysis |
0.0 |
0 |
104396 |
2947 |
Crl:LE |
serum beta-2 microglobulin |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
65.7 |
ug/ml |
7.74 |
17.3 |
automated serum protein analysis |
0.0 |
0 |
104399 |
2947 |
LE-Lrrk2em1Sage-/- |
serum calbindin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
0.5 |
ng/ml |
0.04 |
0.1 |
automated serum protein analysis |
0.0 |
0 |
104402 |
2947 |
LE-Lrrk2em1Sage-/- |
serum clusterin level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
172.0 |
ng/ml |
16.99 |
38.0 |
automated serum protein analysis |
0.0 |
0 |
104404 |
2947 |
LE-Lrrk2em1Sage-/- |
serum glutathione S-transferase-u level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
3.9 |
ug/ml |
1.07 |
2.4 |
automated serum protein analysis |
0.0 |
0 |
104410 |
2947 |
LE-Lrrk2em1Sage-/- |
serum tissue inhibitor of metalloproteinase 1 level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
7.5 |
ng/ml |
0.54 |
1.2 |
automated serum protein analysis |
0.0 |
0 |
104412 |
2947 |
SS.SHR-(D2Rat61-D2Mco18)/Mco |
serum total protein level |
control condition (for 140 days) |
Garrett MR, et al., Physiol Genomics. 2007 May 15;. |
blood total protein amount |
male |
140 days
| 6 |
6.4 |
g/dl |
0.17 |
0.42 |
automated serum protein analysis |
0.0 |
0 |
67983 |
834 |
Crl:LE |
serum glutathione S-transferase-alpha level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
680.0 |
ng/ml |
181.57 |
406.0 |
automated serum protein analysis |
0.0 |
0 |
104407 |
2947 |
Crl:LE |
serum vascular endothelial growth factor A level |
control condition (for 91 days) |
Ness D, et al., PLoS One. 2013 Jun 14;8(6):e66164. doi: 10.1371/journal.pone.0066164. Print 2013. |
blood protein amount |
male |
91 days
| 5 |
252.0 |
pg/ml |
42.49 |
95.0 |
automated serum protein analysis |
0.0 |
0 |
104413 |
2947 |